 (Jt Clin Pathol 1995;48:946-949) 
The association between Epstein-Barr virus (EBV) and certain B cell neoplasms such as African Burkitt's lymphoma,' nasopharyngeal carcinoma2 and lymphomas associated with congenital or acquired immunodeficiency3 is well known. Nasopharyngeal non-Hodgkin's lymphomas of B EBV may act as an environmental co-factor in the development of non-Hodgkin's lymphomas of the respiratory tract, as this strong association is not recognised between EBV and T cell non-Hodgkin's lymphomas at most other sites, in the absence of immunosuppression. Clinical details recorded on our patients did not include smoking history, so we are unable to state whether this was a common denominator. The findings from this study provide further evidence, in Western European patients, that EBV is present within the genome of cells considered to be lesional in sinonasal lymphomas, particularly angiocentric T cell lymphomas. These data implicate EBV in lymphoid tumorigenesis in the sinonasal region and suggest that antiviral therapy could play a role in the treatment of sinonasal peripheral T cell lymphoma. 
